Financial giants have made a conspicuous bullish move on Alnylam Pharmaceuticals. Our analysis of options history for Alnylam Pharmaceuticals (NASDAQ:ALNY) revealed 10 unusual trades.

Delving into the details, we found 50% of traders were bullish, while 30% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $634,769, and 6 were calls, valued at $679,879.

Projected Price Targets

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $230.0 and $520.0 for Alnylam Pharmaceuticals, spanning the last three months.

Volume & Open Interest Trends

In today's trading context, the average open interest for options of Alnylam Pharmaceuticals stands at 80.33, with a total volume reaching 167.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Alnylam Pharmaceuticals, situated within the strike price corridor from $230.0 to $520.0, throughout the last 30 days.

Alnylam Pharmaceuticals 30-Day Option Volume & Interest Snapshot

Noteworthy Options Activity:

About Alnylam Pharmaceuticals

Current Position of Alnylam Pharmaceuticals

• With a volume of 651,365, the price of ALNY is down 0.0% at $467.55.
• RSI indicators hint that the underlying stock may be overbought.
• Next earnings are expected to be released in 69 days.

Professional Analyst Ratings for Alnylam Pharmaceuticals

5 market experts have recently issued ratings for this stock, with a consensus target price of $421.0.

Turn $1000 into $1270 in just 20 days?

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Alnylam Pharmaceuticals options trades with real-time alerts from Benzinga Pro.